Suryavarta: Benefits, Evidence & Safety
TL;DR
Suryavarta (Chrozophora rottleri), a small silvery-haired herb of the spurge family, is used in Indian folk medicine for wounds, coughs, jaundice, and intestinal worms. Rat studies show moderate anti-inflammatory effects and laboratory tests show antifungal activity, but no human clinical trials exist, so medicinal benefits in people are unproven.
(49 words. Sources: anti-inflammatory rat study, ex vivo/in vivo animal; Shinde & Maske 2026, in vitro; PMC review of traditional uses.)
What it is
Suryavarta (also spelled Suryavarti) is the Sanskrit name for Chrozophora rottleri (Geiseler) Spreng., an erect, silvery-haired annual herb in the spurge family (Euphorbiaceae) (PMC review). Its synonym Croton rottleri appears in older literature, and Indian sources sometimes use the name Chrozophora plicata for the same plant (IJRPR review). Leaves, roots, seeds, and fruits are the parts used in traditional practice.
Phytochemical screening has found alkaloids, tannins, flavonoids, steroids, phenols, saponins, and glycosides in the plant, with the leaves and roots particularly rich in xanthone and chromone glycosides; seed oil is rich in linoleate (IJRPR review).
Traditional use
A peer-reviewed review of medicinal plants documents the folk uses of C. rottleri (local name Suryavarti): stems applied for wound healing, the whole plant used for jaundice and "blood purification," leaves as a laxative and anthelmintic, and fruits for cough and colds (PMC review). These are traditional and folk claims, not clinical proof: modern testing is limited to animal and laboratory studies described below.
What modern research says
Anti-inflammatory activity (animal)
In a carrageenan-induced rat paw-edema model of acute inflammation, hydroalcoholic and methanolic extracts of C. rottleri reduced swelling in a dose-dependent manner at 125, 250, and 500 mg/kg. The 500 mg/kg hydroalcoholic extract inhibited maximal edema by about 50%, compared with about 68% for the reference drug indomethacin (anti-inflammatory study). The same study found no signs of toxicity or mortality in mice at extract doses up to 2,000 mg/kg. Animal inflammation models do not establish anti-inflammatory effects in humans.
Antifungal activity (in vitro)
Shinde and Maske (2026) characterized C. rottleri leaf metabolites by GC-MS and tested the leaf extract against the fungus Fusarium oxysporum in a poisoned-food test, reporting about 88% inhibition of fungal growth (The Pharma Innovation Journal). Note that F. oxysporum is a plant pathogen studied for crop protection: this result says nothing about treating fungal infections in people.
What the evidence does not support (yet)
No human trials of Suryavarta were found. The traditional uses for wounds, jaundice, coughs, and worms have not been clinically tested, and the existing evidence consists of one small animal inflammation study and laboratory antifungal work. Claims of therapeutic benefit in humans are ahead of the data.
Safety & contraindications
Safety data is limited: talk to a clinician. The only toxicity information available is an animal study in which mice showed no adverse signs at extract doses up to 2,000 mg/kg (anti-inflammatory study); this does not establish safety in humans. Avoid use during pregnancy and breastfeeding, and do not use it as a substitute for proven treatments for wounds, jaundice, or infections.
FAQs
What is Suryavarta?
Suryavarta is the Sanskrit name for Chrozophora rottleri, a small erect herb with silvery hairs in the spurge family (Euphorbiaceae), found across India, Pakistan, Myanmar, and parts of Africa and Australia (IJRPR review). Indian folk medicine uses its stems, leaves, roots, seeds, and fruits for wounds, coughs, jaundice, and intestinal worms.
Does Suryavarta reduce inflammation?
In rats, possibly: extracts of the plant reduced carrageenan-induced paw swelling dose-dependently, with the highest tested dose inhibiting maximal edema by roughly 50% versus about 68% for indomethacin (anti-inflammatory study). But animal inflammation models are not proof of anti-inflammatory effects in people, and no human trials exist.
Can Suryavarta heal wounds?
There is no clinical evidence. Traditional practice applies the stems to wounds (PMC review), and a rat study found the extracts moderately anti-inflammatory, but no study has tested wound healing with Suryavarta in humans or in a wound model. Wounds should be managed with proven wound care.
Is Suryavarta the same as Chrozophora plicata?
The names are used interchangeably in some Indian sources: a pharmacological review notes that "*Chrozophora plicata* in Indian vegetations is known as Chrozophora rottleri" (IJRPR review). Taxonomically they are listed as separate species, so products or studies under either name should be read carefully for which plant was actually used.
Is Suryavarta safe?
Safety data is limited: talk to a clinician. A mouse study reported no toxicity signs at extract doses up to 2,000 mg/kg, but animal data cannot establish human safety (anti-inflammatory study). Avoid it during pregnancy and breastfeeding and do not substitute it for prescribed medicines.
Sources
- Sathish R, Chandy V, Visagaperumal D. "Review of pharmacological activities of Chrozophora rottleri." International Journal of Research in Pharmacy and Pharmaceutical Sciences — ijrpr.com
- "Anti-Inflammatory Activity of Chrozophora rottleri Extracts on Carrageenan-Induced Rat Paw Edema" (includes acute toxicity data in mice) — pdfs.semanticscholar.org
- Shinde SN, Maske VS. "GC-MS characterisation and in-vitro antifungal activity of Chrozophora rottleri (Geiseler) A. Juss. ex-Spreng. leaf metabolites against Fusarium oxysporum." The Pharma Innovation Journal. 2026;15(4):17–23. DOI: 10.22271/tpi.2026.v15.i4a.26446 — thepharmajournal.com
- "Review on Medicinal and Pharmacological Properties of Iresine Herbstii, Chrozophora Rottleri and Ecbolium Linneanum" (traditional uses table). PMC — PMC · PMC3252720
Related herbs
Disclaimer
This article is for educational purposes only and is not medical advice. Herbal products can interact with medications and are not suitable for everyone. Talk to a qualified healthcare practitioner before use — especially if you are pregnant, breastfeeding, managing a medical condition, or taking prescription medicines.